TYK2 inhibitor Promising for Psoriasis in Phase 3 Studies

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety concerns emerging.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/tyk2-inhibitor-promising-moderate-severe-psoriasis-phase-3-2026a10009tm?src=rss

Author :

Publish date : 2026-03-31 18:13:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

TYK2 inhibitor Promising for Psoriasis in Phase 3 Studies

FDA Warns of Fatal Liver Injuries Tied to Drug It Wants Pulled From Market

Supreme Court Rules Against Colorado Ban on ‘Conversion Therapy’ for LGBTQ+ Kids

Related Posts

KT Tape May Not Be All That Helpful for Joint, Muscle Pain

Should I Watch That ‘Bachelorette’ Star’s Domestic Violence Video?

Hospitals Need to Up Their Game on the Food They Serve, Federal Officials Say

How Symptoms Affect Social Lives, Loneliness Near Life’s End

Large GLP-1 Drug Review Takes Closer Look at Risks, Rewards

Buyer Beware: Physicians Pivotal in Information Battle on Menopause Hormone Therapy

KT Tape May Not Be All That Helpful for Joint, Muscle Pain

Should I Watch That ‘Bachelorette’ Star’s Domestic Violence Video?

Hospitals Need to Up Their Game on the Food They Serve, Federal Officials Say

How Symptoms Affect Social Lives, Loneliness Near Life’s End

Large GLP-1 Drug Review Takes Closer Look at Risks, Rewards

Buyer Beware: Physicians Pivotal in Information Battle on Menopause Hormone Therapy

Ex-Arkansas Medical Board Chair Indicted for Alleged Drugging, Abduction of Patients

What Drives Amish Superagers; Parkinson’s Data Flagged; A Look at Childhood Dementia

Categories

Archives